EU rules may be stifling Britain’s biotech industry
November 19, 2018Sales and Marketing EU, biotech, britain, funding, grants, industry
EU rules are stifling Britain’s biotech industry, according to companies who talked to British newspaper The Daily Telegraph. The newspaper …
MSD’s Keytruda to treat melanoma in England on the Cancer Drugs Fund
November 19, 2018Sales and Marketing England, MSD, NHS, UK, keytruda, melanoma, pharma
MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) will now be made available to patients in England via the Cancer Drugs Fund, it …
FDA trial may help to cut the number of dogs used in clinical trials
November 19, 2018Sales and Marketing Animal testing, animal activists, clinical trials, dogs, health, tests
A new study may help to significantly reduce the number of dogs that are used in clinical trials, according to …
Alector strengthens board with three appointments including Facebook CFO David Wehner
November 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Facebook’s Chief Financial Officer (CFO) David Wehner has joined the board of San Francisco-based biotech Alector, a company that hopes …
AstraZeneca’s Imfinzi immunotherapy combo fails to show benefit in lung cancer
November 16, 2018Medical Communications, Research and Development AstraZeneca, Cancer, Imfinzi, lung cancer, pharma
AstraZeneca has revealed that its immunotherapy combo of Imfinzi (durvalumab) and tremelimumab failed to meet its primary endpoint in a …
Top Ten most popular articles on Pharmafile.com this week!
November 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Korea, NICE, Samsung, Theresa May, UK, brexit, politics, top 10
The Samsung scandal played a prominent role in this weeks’ top ten after the South Korean firm was delisted from …
Boehringer signs $300 million deal with Epizyme over epigenetic cancer treatment
November 16, 2018Medical Communications Boehringer, Cancer, Epizyme, deal, oncology
German firm Boehringer Ingelheim and the Massachusetts-based biotech Epizyme have announced that they will collaborate on the development of novel, …
United Therapeutics buys Arena’s hypertension drug ralinepag in deal worth $1.2 billion
November 16, 2018Medical Communications Arena, PAH, United Therapeutics, deal sales, hypertension
US pharma firm United Therapeutics has agreed to by Arena Pharmaceuticals experimental pulmonary arterial hypertension (PAH) drug ralinepag in a …
Ipsen’s Cabometyx gains European approval in hepatocellular carcinoma
November 16, 2018Medical Communications, Sales and Marketing Cabometyx, carcinoma, ipsen, pharma. European Commission
Ipsen’s Cabometyx has received approval from the European Commission for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular …
Dermavant appoint Todd Zavodnick as CEO
November 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Roivant subsidiary Dermavant has appointed experienced pharma exec Todd Zavodnick as the company’s new CEO. The Rutger’s University graduate will …
Rising to the challenge of delivering therapeutic discovery for mental disorders
November 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NIHRm, Oxford, R&D, feature, investment, mental health
Professor Matthew Hotopf, Director of NIHR Maudsley Biomedical Research Centre, and Professor John R Geddes, Director of NIHR Oxford Health …
Kymriah to be made available in UK for paediatric leukaemia patients via Cancer Drugs Fund
November 15, 2018Sales and Marketing CAR-T, Cancer, Cancer Drugs Fund, Kymriah, NHS, NICE, leukaemia, pharma
NICE has announced its recommendation that Novartis’ CAR-T cell therapy Kymriah (tisagenlecleucel) be made available in the treatment of relapsed …
MSD’s Keytruda improvess overall survival in Phase 3 oesophageal cancer
November 15, 2018Research and Development Cancer, MSD, PD-L1, keytruda, pharma
MSD has announced new Phase 3 data on its anti-PD-1 therapy Keytruda (pembrolizumab) as a second-line treatment for advanced or …
Phamaceutical trade lobby responds to Brexit deal
November 15, 2018Business Services, Medical Communications, Research and Development ABPI, brexit, negotiations, pharma, politics
The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a …
Pfizer defeated in Britain’s highest court over Lyrica patent
November 15, 2018Business Services, Medical Communications Legislation, Lyrica, Pfizer, court, pharma
American pharma firm Pfizer have lost in the final round of a protracted court battle over the patent on epilepsy …
Novartis denies potential split with Sandoz
November 15, 2018Business Services, Manufacturing and Production Business, M&A, MA, Novartis, Sandoz, acquisition, mergers
Swiss newspaper Tages-Anzeiger has reported that Novartis is preparing for a split with long-term partner Sandoz. The two companies merged …
Company tackling antimicrobial resistance appoint former Bayer VP as new managing director
November 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
British company Matoke Pharma have appointed former Bayer VP, Alan Westwood, as the firm’s new managing director, a role in …
3 in 4 UK diabetes patients suffer from mental health issues, says report
November 14, 2018Medical Communications, Research and Development UK, World Diabetes Day, diabetes, pharma
To mark this year’s World Diabetes Day on 14 November, a new report has shed more light on the psychological …
German health minister Jens Spahn calls for faster adoption of biosimilars
November 14, 2018Research and Development AbbVie, Germany, biosimilars, jens Spahn
Germany’s health minister Jens Spahn has called for faster uptake of biosimilars in an effort to cut the cost of …
Ebola outbreak in Congo may last another 6 months, WHO officials say
November 14, 2018Research and Development Congo, Ebola, WHO, health, infectious diseases
The outbreak of Ebola in the Democratic Republic of Congo (DRC) is expected to last until mid-2019, a World Health …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
